Heathcare Treasure

Alpha thalassemia, a hereditary blood disorder, has posed significant health challenges in the MENA (Middle East and North Africa) region. However, recent advancements in newborn screening, genetic counseling, and emerging alpha thalassemia drug therapies are shaping a brighter future for individuals affected by this condition. In this blog, we explore the current state of these key components of alpha thalassemia management. Current State of Newborn Screening (NBS) and Genetic Counseling in the MENA Region Newborn screening (NBS) is the first crucial step in identifying alpha thalassemia cases early. The MENA region has made substantial progress in implementing NBS programs to detect the disorder in newborns, allowing for prompt intervention and support. Genetic counseling plays a pivotal role in providing families with information and support to make informed decisions about their reproductive choices. Its availability and accessibility in the MENA region have improved significantl